Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$36,749,905
+$11,560,590 QoQ
Shares Held
290,881
+60.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#250
of 2,266 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $365,428,487 across 9 Drug Manufacturers - General names. GILD ranks #3 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
669,135 | $169,940,215 | |
| 2 | LLY |
ELI LILLY & Co
|
87,023 | $104,378,005 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
290,881 | $36,749,905 | |
| 4 | GSK |
GSK plc
|
504,171 | $26,428,643 | |
| 5 | SNY |
Sanofi
|
206,873 | $8,825,202 | |
| 6 | AMGN |
Amgen Inc
|
21,869 | $7,919,202 | |
| 7 | PFE |
Pfizer Inc
|
180,092 | $4,336,615 | |
| 8 | MRK |
Merck & Co., Inc.
|
30,254 | $3,887,639 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,749,905 | 290,881 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,189,315 | 180,737 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,889,912 | 292,406 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $42,775,404 | 385,364 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $73,872,681 | 666,300 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $56,355,883 | 502,953 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $42,576,658 | 460,936 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,350,017 | 206,942 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $54,246,084 | 790,644 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $74,112,006 | 1,011,768 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $65,449,518 | 807,919 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $54,894,374 | 732,511 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $57,471,869 | 745,710 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $41,206,967 | 496,649 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,909,911 | 278,508 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $17,698,861 | 286,900 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $36,188,766 | 585,484 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $19,147,180 | 322,072 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,132,250 | 43,138 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,116,637 | 44,619 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,725,250 | 126,710 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,980,690 | 61,592 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,947,956 | 50,600 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||